Loading...

Digitalisation and Smart Financing key to sustainable growth in healthcare

Image

24-Feb-16 Siemens has released a new report based on research with healthcare providers across 13 countries including India, China, Poland, Russia and Turkey, which revealed four common pressures: demographic change; shifting patient expectations; requirement to reform; and the rising tide of healthcare technology. Digitalisation and smart financing have been recognised as the ultimate remedy for the increasing pressures on healthcare. [image: SFS]

Read More

Iran, Russia sign three medical MOUs

Image

21-Feb-16 Iran and Russia have inked three memoranda of understanding to boost medical cooperation, ranging from exchanging knowledge and technology to importing and exporting medications. Iranian pharma companies are eager to export their products to Russia and Russian officials are optimistic. [image: Tehran Times]

Read More

12 Healthcare growth markets stories from 2015, month-by-month

Image

18-Jan-16 As the healthcare industry considers the possibilities - and challenges - of the year ahead, here's a look back at 12 notable Healthcare growth markets stories from 2015 you may have missed, month-by-month, including "China’s physicians encouraged to take up second jobs", "Vietnam achieves healthcare Millennium Development Goals", "World's biggest healthcare facility financed in Turkey" and more.

Read More

Russia to permit online sales of medicines from 2017

Image

28-Dec-15 Russia plans to allow drugstore chains to sell medicines via the Internet as of 1-Jan-17. "This type of selling the drugs will be accessible to all customers with access to the Internet and cover all the groups of medicines, except narcotics and psychotropic substances," the government press service said. [image: Retail & Loyalty]

Read More

Foreign pharma faces tough choices in Russia

Image

01-Dec-15 When in May-15 Prime Minister Dmitry Medvedev tasked the government with creating a program of pharmaceutical import substitution, foreign companies were worried. Today, 60% of the drugs approved by the Russian government are produced domestically. Under the new policy, this share should increase to 90% by 2018. [image: Getty Images]

Read More
Share